Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Down, Turner and Klinefelter syndromes

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Recognise Down, Turner and Klinefelter syndromes across childhood, confirm the chromosome diagnosis, anticipate age-specific health needs, support development and identity, and coordinate endocrine, cardiac, fertility and transition care.

  • Down syndrome is usually trisomy 21; confirm the chromosome result and distinguish free trisomy, translocation and mosaicism because parental testing and recurrence advice differ.
  • Every newborn with Down syndrome needs a full blood count and peripheral blood film by day three to screen for transient abnormal myelopoiesis, plus a defined cardiac pathway even when the initial examination appears reassuring.
  • Turner syndrome should be considered in unexplained short stature, neonatal lymphoedema, left-sided cardiac lesions, delayed puberty, primary amenorrhoea or ovarian insufficiency.
  • A confirmed Turner diagnosis needs expert cardiac imaging and blood-pressure surveillance, renal assessment, hearing care, thyroid and metabolic monitoring, growth review and planned pubertal induction.
  • Klinefelter syndrome may present with language or learning needs, tall stature, small firm testes, incomplete virilisation, gynaecomastia, infertility or hypergonadotrophic hypogonadism.
  • Chromosome results do not predict personality, ability, gender identity, sexuality, fertility or severity; use person-centred language and assess the individual rather than a stereotype.
  • Discuss puberty and fertility progressively in private as well as with family, offering preservation or reproductive advice early enough for meaningful choice.
  • Coordinate school support, reasonable adjustments, transition and adult follow-up; avoid allowing a familiar syndrome label to obscure a new treatable symptom.

Key red flags

A newborn with suspected Down syndrome who is cyanosed, tachypnoeic, poorly feeding or shocked needs urgent assessment for congenital heart disease and other neonatal illness.

Bilious vomiting, marked abdominal distension or failure to pass meconium in an infant with Down syndrome requires emergency surgical evaluation for obstruction.

New gait change, limb weakness, neck pain, sphincter disturbance or upper motor-neurone signs in Down syndrome raises possible cervical cord compression and needs urgent imaging advice.

A child with Turner syndrome and chest or back pain, collapse, severe hypertension or acute breathlessness requires emergency assessment for aortic disease.

Headache, visual symptoms or severe hypertension in a child receiving growth hormone or sex steroids requires prompt endocrine review and assessment for treatment complications.

Acute testicular pain in any boy or young man, including someone with Klinefelter syndrome, follows the emergency torsion pathway rather than being attributed to the chromosome diagnosis.

Investigation priorities

01
Chromosome analysisFirst step

Confirm chromosome number, mosaicism or a structural rearrangement underlying the phenotype.

Management branches

ConfirmDefine the chromosome diagnosis

Prenatal, newborn, growth, developmental or pubertal features suggest aneuploidy.

  1. Stabilise urgent clinical problems and document the complete phenotype without delaying necessary care.
  2. Request the eligible chromosome test and obtain genetics or paediatric interpretation of the exact result.
  3. Explain mosaic or structural findings and arrange parental studies when they change recurrence counselling.

Key medicines

Somatropin in Turner syndromeA paediatric endocrine specialist selects a daily subcutaneous weight- or surface-area-based regimen under the current product licence and growth protocol, titrating against growth response and IGF-1 rather than using a fixed adult dose.Monitor growth velocity, IGF-1, glucose, thyroid function, headache, visual symptoms, hip or knee pain and scoliosis; pause and investigate possible intracranial hypertension or slipped epiphysis promptly.
Oestradiol for pubertal inductionBegin with a very low specialist transdermal or oral oestradiol dose and increase stepwise over roughly two to three years toward adult replacement; add progestogen after sufficient oestrogen exposure or bleeding according to the individual plan.Avoid immediate adult dosing, review migraine and thrombotic context, monitor blood pressure, growth, pubertal progress and bleeding, and coordinate fertility and cardiac considerations in Turner syndrome.
Open full textbook →Answer 2 questions
Sources and review status7 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS Down syndrome overviewDiagnosis, associated health needs, development and support for people with Down syndrome.
  • DSMIG neonatal Down syndrome guidanceUK specialist neonatal surveillance route, including congenital heart disease and transient abnormal myelopoiesis screening.
  • DSMIG haematological conditionsDay-three full blood count and film, blast interpretation, GATA1 testing and urgent referral for neonatal TAM.
  • DSMIG cervical spine disordersCurrent warning features and urgent response for symptomatic craniovertebral instability.
  • NHS Turner syndrome overviewClinical features, growth, ovarian insufficiency, treatment and long-term monitoring.
  • NHS Klinefelter syndrome overviewChildhood and adult presentation, diagnostic testing, endocrine treatment and fertility context.
  • BSPED clinical guidelinesUK paediatric endocrine resources relevant to growth and pubertal induction.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem ·

Content changes
Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom